Healthcare Industry Trends
2024 Mid-Year Report 

Download now

Key takeaways

 
Our Healthcare Investments & Exits Mid-Year Report for 2024 examines the impact of fundraising, investment and exit trends on the VC-backed healthcare ecosystem.

55

Biopharma companies have landed deals of $100M and above so far this year.

2024 is on track to set the record for deals of this size within the sector.

89%

of US VC funds with a healthcare focus have hit fundraising targets in the first half of 2024.

This level of success outstrips all prior years except 2022.

More than 1 in 4

US healthcare companies that closed a venture capital deal of at least $15M reported a flat or down round in 2024.

This marks the highest proportion of down rounds in recent history.